☰

Mitchell E. Gross, Ph.D.

Affiliations: 
2003 University of California, Los Angeles, Los Angeles, CA 
Area:
Molecular Biology, Oncology
Google:
"Mitchell Gross"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor
Ke Shuai grad student 2003 UCLA
 (Protein inhibitor of activated STAT y (PIASy) in androgen receptor signaling and prostate cancer.)

Children

Sign in to add trainee

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Jacobs MR, Olivero JE, Ok Choi H, et al. (2023) Synthesis and anti-cancer potential of potent peripheral MAOA inhibitors designed to limit blood:brain penetration. Bioorganic & Medicinal Chemistry. 92: 117425
Gross ME, Agus DB, Dorff TB, et al. (2020) Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer. Prostate Cancer and Prostatic Diseases
Dorff TB, Quinn DI, Pinski JK, et al. (2019) Randomized Phase II Trial of Abiraterone Alone or With Dasatinib in Men With Metastatic Castration-resistant Prostate Cancer (mCRPC). Clinical Genitourinary Cancer
Gaur S, Gross ME, Liao CP, et al. (2019) Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells. The Prostate
Liao CP, Lin TP, Li PC, et al. (2018) Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate. Oncogene
Belic J, Graf R, Bauernhofer T, et al. (2018) Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide. International Journal of Cancer
Gross ME, Dorff TB, Quinn DI, et al. (2017) Safety and Efficacy of Docetaxel, Bevacizumab, and Everolimus for Castration-resistant Prostate Cancer (CRPC). Clinical Genitourinary Cancer
Liao CP, Chen LY, Luethy A, et al. (2017) Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells. Endocrine-Related Cancer. 24: 157-170
Kiwata JL, Dorff TB, Schroeder ET, et al. (2016) A review of clinical effects associated with metabolic syndrome and exercise in prostate cancer patients Prostate Cancer and Prostatic Diseases
Gross ME. (2015) Blood-based gene expression profiling in castrate-resistant prostate cancer. Bmc Medicine. 13: 219
See more...